Pharma & Healthcare

Global Dry Eye Syndrome Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

The global Dry Eye Syndrome market is strategically segmented by company, region (country), by Type, and by Distribution Channel. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Distribution Channel for 2020-2031.
Market Segmentation
By Company:
AbbVie
Alcon
Novartis
Santen Pharma
Johnson & Johnson
Bausch & Lomb
Thea pharmaceuticals
URSAPHARM
SIMILASAN
Akorn
United Laboratories
Sun Pharmaceutical
Jianfeng Group
OmniVision Pharma
Rohto
Prestige Consumer Healthcare
LION
Kenvue (VISINE)
By Type: (Dominant Segment vs High-Margin Innovation)
Artificial Tears
Anti-inflammatory Drugs
Others
By Application: (Core Demand Driver vs Emerging Opportunity)
Hospital
Retail Pharmacy
Others
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., AbbVie in Europe)
- Emerging Product Trends: Artificial Tears adoption vs. Anti-inflammatory Drugs premiumization
- Demand-Side Dynamics: Hospital growth in China vs. Retail Pharmacy potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
India
(Additional regions can be customized based on client needs.)
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Dry Eye Syndrome market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Anti-inflammatory Drugs in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Retail Pharmacy in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Artificial Tears dominance in Europe vs. Anti-inflammatory Drugs demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
1 Market Overview
1.1 Dry Eye Syndrome Product Scope
1.2 Dry Eye Syndrome by Type
1.2.1 Global Dry Eye Syndrome Sales by Type (2020 & 2024 & 2031)
1.2.2 Artificial Tears
1.2.3 Anti-inflammatory Drugs
1.2.4 Others
1.3 Dry Eye Syndrome by Distribution Channel
1.3.1 Global Dry Eye Syndrome Sales Comparison by Distribution Channel (2020 & 2024 & 2031)
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Global Dry Eye Syndrome Market Estimates and Forecasts (2020-2031)
1.4.1 Global Dry Eye Syndrome Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Dry Eye Syndrome Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Dry Eye Syndrome Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Dry Eye Syndrome Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Dry Eye Syndrome Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Dry Eye Syndrome Sales Market Share by Region (2020-2025)
2.2.2 Global Dry Eye Syndrome Revenue Market Share by Region (2020-2025)
2.3 Global Dry Eye Syndrome Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Dry Eye Syndrome Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Dry Eye Syndrome Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Dry Eye Syndrome Market Size and Prospective (2020-2031)
2.4.2 Europe Dry Eye Syndrome Market Size and Prospective (2020-2031)
2.4.3 China Dry Eye Syndrome Market Size and Prospective (2020-2031)
2.4.4 Japan Dry Eye Syndrome Market Size and Prospective (2020-2031)
2.4.5 India Dry Eye Syndrome Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Dry Eye Syndrome Historic Market Review by Type (2020-2025)
3.1.1 Global Dry Eye Syndrome Sales by Type (2020-2025)
3.1.2 Global Dry Eye Syndrome Revenue by Type (2020-2025)
3.1.3 Global Dry Eye Syndrome Price by Type (2020-2025)
3.2 Global Dry Eye Syndrome Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Dry Eye Syndrome Sales Forecast by Type (2026-2031)
3.2.2 Global Dry Eye Syndrome Revenue Forecast by Type (2026-2031)
3.2.3 Global Dry Eye Syndrome Price Forecast by Type (2026-2031)
3.3 Different Types Dry Eye Syndrome Representative Players
4 Global Market Size by Distribution Channel
4.1 Global Dry Eye Syndrome Historic Market Review by Distribution Channel (2020-2025)
4.1.1 Global Dry Eye Syndrome Sales by Distribution Channel (2020-2025)
4.1.2 Global Dry Eye Syndrome Revenue by Distribution Channel (2020-2025)
4.1.3 Global Dry Eye Syndrome Price by Distribution Channel (2020-2025)
4.2 Global Dry Eye Syndrome Market Estimates and Forecasts by Distribution Channel (2026-2031)
4.2.1 Global Dry Eye Syndrome Sales Forecast by Distribution Channel (2026-2031)
4.2.2 Global Dry Eye Syndrome Revenue Forecast by Distribution Channel (2026-2031)
4.2.3 Global Dry Eye Syndrome Price Forecast by Distribution Channel (2026-2031)
4.3 New Sources of Growth in Dry Eye Syndrome Application
5 Competition Landscape by Players
5.1 Global Dry Eye Syndrome Sales by Players (2020-2025)
5.2 Global Top Dry Eye Syndrome Players by Revenue (2020-2025)
5.3 Global Dry Eye Syndrome Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dry Eye Syndrome as of 2024)
5.4 Global Dry Eye Syndrome Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Dry Eye Syndrome, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Dry Eye Syndrome, Product Type & Application
5.7 Global Key Manufacturers of Dry Eye Syndrome, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Dry Eye Syndrome Sales by Company
6.1.1.1 North America Dry Eye Syndrome Sales by Company (2020-2025)
6.1.1.2 North America Dry Eye Syndrome Revenue by Company (2020-2025)
6.1.2 North America Dry Eye Syndrome Sales Breakdown by Type (2020-2025)
6.1.3 North America Dry Eye Syndrome Sales Breakdown by Distribution Channel (2020-2025)
6.1.4 North America Dry Eye Syndrome Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Dry Eye Syndrome Sales by Company
6.2.1.1 Europe Dry Eye Syndrome Sales by Company (2020-2025)
6.2.1.2 Europe Dry Eye Syndrome Revenue by Company (2020-2025)
6.2.2 Europe Dry Eye Syndrome Sales Breakdown by Type (2020-2025)
6.2.3 Europe Dry Eye Syndrome Sales Breakdown by Distribution Channel (2020-2025)
6.2.4 Europe Dry Eye Syndrome Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Dry Eye Syndrome Sales by Company
6.3.1.1 China Dry Eye Syndrome Sales by Company (2020-2025)
6.3.1.2 China Dry Eye Syndrome Revenue by Company (2020-2025)
6.3.2 China Dry Eye Syndrome Sales Breakdown by Type (2020-2025)
6.3.3 China Dry Eye Syndrome Sales Breakdown by Distribution Channel (2020-2025)
6.3.4 China Dry Eye Syndrome Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Dry Eye Syndrome Sales by Company
6.4.1.1 Japan Dry Eye Syndrome Sales by Company (2020-2025)
6.4.1.2 Japan Dry Eye Syndrome Revenue by Company (2020-2025)
6.4.2 Japan Dry Eye Syndrome Sales Breakdown by Type (2020-2025)
6.4.3 Japan Dry Eye Syndrome Sales Breakdown by Distribution Channel (2020-2025)
6.4.4 Japan Dry Eye Syndrome Major Customer
6.4.5 Japan Market Trend and Opportunities
6.5 India Market: Players, Segments, Downstream and Major Customers
6.5.1 India Dry Eye Syndrome Sales by Company
6.5.1.1 India Dry Eye Syndrome Sales by Company (2020-2025)
6.5.1.2 India Dry Eye Syndrome Revenue by Company (2020-2025)
6.5.2 India Dry Eye Syndrome Sales Breakdown by Type (2020-2025)
6.5.3 India Dry Eye Syndrome Sales Breakdown by Distribution Channel (2020-2025)
6.5.4 India Dry Eye Syndrome Major Customer
6.5.5 India Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 AbbVie
7.1.1 AbbVie Company Information
7.1.2 AbbVie Business Overview
7.1.3 AbbVie Dry Eye Syndrome Sales, Revenue and Gross Margin (2020-2025)
7.1.4 AbbVie Dry Eye Syndrome Products Offered
7.1.5 AbbVie Recent Development
7.2 Alcon
7.2.1 Alcon Company Information
7.2.2 Alcon Business Overview
7.2.3 Alcon Dry Eye Syndrome Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Alcon Dry Eye Syndrome Products Offered
7.2.5 Alcon Recent Development
7.3 Novartis
7.3.1 Novartis Company Information
7.3.2 Novartis Business Overview
7.3.3 Novartis Dry Eye Syndrome Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Novartis Dry Eye Syndrome Products Offered
7.3.5 Novartis Recent Development
7.4 Santen Pharma
7.4.1 Santen Pharma Company Information
7.4.2 Santen Pharma Business Overview
7.4.3 Santen Pharma Dry Eye Syndrome Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Santen Pharma Dry Eye Syndrome Products Offered
7.4.5 Santen Pharma Recent Development
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Company Information
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Dry Eye Syndrome Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Johnson & Johnson Dry Eye Syndrome Products Offered
7.5.5 Johnson & Johnson Recent Development
7.6 Bausch & Lomb
7.6.1 Bausch & Lomb Company Information
7.6.2 Bausch & Lomb Business Overview
7.6.3 Bausch & Lomb Dry Eye Syndrome Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Bausch & Lomb Dry Eye Syndrome Products Offered
7.6.5 Bausch & Lomb Recent Development
7.7 Thea pharmaceuticals
7.7.1 Thea pharmaceuticals Company Information
7.7.2 Thea pharmaceuticals Business Overview
7.7.3 Thea pharmaceuticals Dry Eye Syndrome Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Thea pharmaceuticals Dry Eye Syndrome Products Offered
7.7.5 Thea pharmaceuticals Recent Development
7.8 URSAPHARM
7.8.1 URSAPHARM Company Information
7.8.2 URSAPHARM Business Overview
7.8.3 URSAPHARM Dry Eye Syndrome Sales, Revenue and Gross Margin (2020-2025)
7.8.4 URSAPHARM Dry Eye Syndrome Products Offered
7.8.5 URSAPHARM Recent Development
7.9 SIMILASAN
7.9.1 SIMILASAN Company Information
7.9.2 SIMILASAN Business Overview
7.9.3 SIMILASAN Dry Eye Syndrome Sales, Revenue and Gross Margin (2020-2025)
7.9.4 SIMILASAN Dry Eye Syndrome Products Offered
7.9.5 SIMILASAN Recent Development
7.10 Akorn
7.10.1 Akorn Company Information
7.10.2 Akorn Business Overview
7.10.3 Akorn Dry Eye Syndrome Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Akorn Dry Eye Syndrome Products Offered
7.10.5 Akorn Recent Development
7.11 United Laboratories
7.11.1 United Laboratories Company Information
7.11.2 United Laboratories Business Overview
7.11.3 United Laboratories Dry Eye Syndrome Sales, Revenue and Gross Margin (2020-2025)
7.11.4 United Laboratories Dry Eye Syndrome Products Offered
7.11.5 United Laboratories Recent Development
7.12 Sun Pharmaceutical
7.12.1 Sun Pharmaceutical Company Information
7.12.2 Sun Pharmaceutical Business Overview
7.12.3 Sun Pharmaceutical Dry Eye Syndrome Sales, Revenue and Gross Margin (2020-2025)
7.12.4 Sun Pharmaceutical Dry Eye Syndrome Products Offered
7.12.5 Sun Pharmaceutical Recent Development
7.13 Jianfeng Group
7.13.1 Jianfeng Group Company Information
7.13.2 Jianfeng Group Business Overview
7.13.3 Jianfeng Group Dry Eye Syndrome Sales, Revenue and Gross Margin (2020-2025)
7.13.4 Jianfeng Group Dry Eye Syndrome Products Offered
7.13.5 Jianfeng Group Recent Development
7.14 OmniVision Pharma
7.14.1 OmniVision Pharma Company Information
7.14.2 OmniVision Pharma Business Overview
7.14.3 OmniVision Pharma Dry Eye Syndrome Sales, Revenue and Gross Margin (2020-2025)
7.14.4 OmniVision Pharma Dry Eye Syndrome Products Offered
7.14.5 OmniVision Pharma Recent Development
7.15 Rohto
7.15.1 Rohto Company Information
7.15.2 Rohto Business Overview
7.15.3 Rohto Dry Eye Syndrome Sales, Revenue and Gross Margin (2020-2025)
7.15.4 Rohto Dry Eye Syndrome Products Offered
7.15.5 Rohto Recent Development
7.16 Prestige Consumer Healthcare
7.16.1 Prestige Consumer Healthcare Company Information
7.16.2 Prestige Consumer Healthcare Business Overview
7.16.3 Prestige Consumer Healthcare Dry Eye Syndrome Sales, Revenue and Gross Margin (2020-2025)
7.16.4 Prestige Consumer Healthcare Dry Eye Syndrome Products Offered
7.16.5 Prestige Consumer Healthcare Recent Development
7.17 LION
7.17.1 LION Company Information
7.17.2 LION Business Overview
7.17.3 LION Dry Eye Syndrome Sales, Revenue and Gross Margin (2020-2025)
7.17.4 LION Dry Eye Syndrome Products Offered
7.17.5 LION Recent Development
7.18 Kenvue (VISINE)
7.18.1 Kenvue (VISINE) Company Information
7.18.2 Kenvue (VISINE) Business Overview
7.18.3 Kenvue (VISINE) Dry Eye Syndrome Sales, Revenue and Gross Margin (2020-2025)
7.18.4 Kenvue (VISINE) Dry Eye Syndrome Products Offered
7.18.5 Kenvue (VISINE) Recent Development
8 Dry Eye Syndrome Manufacturing Cost Analysis
8.1 Dry Eye Syndrome Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Dry Eye Syndrome
8.4 Dry Eye Syndrome Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Dry Eye Syndrome Distributors List
9.3 Dry Eye Syndrome Customers
10 Dry Eye Syndrome Market Dynamics
10.1 Dry Eye Syndrome Industry Trends
10.2 Dry Eye Syndrome Market Drivers
10.3 Dry Eye Syndrome Market Challenges
10.4 Dry Eye Syndrome Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
List of Tables
Table 1. Global Dry Eye Syndrome Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Dry Eye Syndrome Sales (US$ Million) Comparison by Distribution Channel (2020 & 2024 & 2031)
Table 3. Global Market Dry Eye Syndrome Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Dry Eye Syndrome Sales (K Units) by Region (2020-2025)
Table 5. Global Dry Eye Syndrome Sales Market Share by Region (2020-2025)
Table 6. Global Dry Eye Syndrome Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Dry Eye Syndrome Revenue Share by Region (2020-2025)
Table 8. Global Dry Eye Syndrome Sales (K Units) Forecast by Region (2026-2031)
Table 9. Global Dry Eye Syndrome Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Dry Eye Syndrome Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Dry Eye Syndrome Revenue Share Forecast by Region (2026-2031)
Table 12. Global Dry Eye Syndrome Sales by Type (K Units) & (2020-2025)
Table 13. Global Dry Eye Syndrome Sales Share by Type (2020-2025)
Table 14. Global Dry Eye Syndrome Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Dry Eye Syndrome Price by Type (US$/Unit) & (2020-2025)
Table 16. Global Dry Eye Syndrome Sales by Type (K Units) & (2026-2031)
Table 17. Global Dry Eye Syndrome Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Dry Eye Syndrome Price by Type (US$/Unit) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Dry Eye Syndrome Sales by Distribution Channel (K Units) & (2020-2025)
Table 21. Global Dry Eye Syndrome Sales Share by Distribution Channel (2020-2025)
Table 22. Global Dry Eye Syndrome Revenue by Distribution Channel (US$ Million) & (2020-2025)
Table 23. Global Dry Eye Syndrome Price by Distribution Channel (US$/Unit) & (2020-2025)
Table 24. Global Dry Eye Syndrome Sales by Distribution Channel (K Units) & (2026-2031)
Table 25. Global Dry Eye Syndrome Revenue Market Share by Distribution Channel (US$ Million) & (2026-2031)
Table 26. Global Dry Eye Syndrome Price by Distribution Channel (US$/Unit) & (2026-2031)
Table 27. New Sources of Growth in Dry Eye Syndrome Application
Table 28. Global Dry Eye Syndrome Sales by Company (K Units) & (2020-2025)
Table 29. Global Dry Eye Syndrome Sales Share by Company (2020-2025)
Table 30. Global Dry Eye Syndrome Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Dry Eye Syndrome Revenue Share by Company (2020-2025)
Table 32. Global Dry Eye Syndrome by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dry Eye Syndrome as of 2024)
Table 33. Global Market Dry Eye Syndrome Average Price by Company (US$/Unit) & (2020-2025)
Table 34. Global Key Manufacturers of Dry Eye Syndrome, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Dry Eye Syndrome, Product Type & Application
Table 36. Global Key Manufacturers of Dry Eye Syndrome, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Dry Eye Syndrome Sales by Company (2020-2025) & (K Units)
Table 39. North America Dry Eye Syndrome Sales Market Share by Company (2020-2025)
Table 40. North America Dry Eye Syndrome Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Dry Eye Syndrome Revenue Market Share by Company (2020-2025)
Table 42. North America Dry Eye Syndrome Sales by Type (2020-2025) & (K Units)
Table 43. North America Dry Eye Syndrome Sales Market Share by Type (2020-2025)
Table 44. North America Dry Eye Syndrome Sales by Distribution Channel (2020-2025) & (K Units)
Table 45. North America Dry Eye Syndrome Sales Market Share by Distribution Channel (2020-2025)
Table 46. Europe Dry Eye Syndrome Sales by Company (2020-2025) & (K Units)
Table 47. Europe Dry Eye Syndrome Sales Market Share by Company (2020-2025)
Table 48. Europe Dry Eye Syndrome Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Dry Eye Syndrome Revenue Market Share by Company (2020-2025)
Table 50. Europe Dry Eye Syndrome Sales by Type (2020-2025) & (K Units)
Table 51. Europe Dry Eye Syndrome Sales Market Share by Type (2020-2025)
Table 52. Europe Dry Eye Syndrome Sales by Distribution Channel (2020-2025) & (K Units)
Table 53. Europe Dry Eye Syndrome Sales Market Share by Distribution Channel (2020-2025)
Table 54. China Dry Eye Syndrome Sales by Company (2020-2025) & (K Units)
Table 55. China Dry Eye Syndrome Sales Market Share by Company (2020-2025)
Table 56. China Dry Eye Syndrome Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Dry Eye Syndrome Revenue Market Share by Company (2020-2025)
Table 58. China Dry Eye Syndrome Sales by Type (2020-2025) & (K Units)
Table 59. China Dry Eye Syndrome Sales Market Share by Type (2020-2025)
Table 60. China Dry Eye Syndrome Sales by Distribution Channel (2020-2025) & (K Units)
Table 61. China Dry Eye Syndrome Sales Market Share by Distribution Channel (2020-2025)
Table 62. Japan Dry Eye Syndrome Sales by Company (2020-2025) & (K Units)
Table 63. Japan Dry Eye Syndrome Sales Market Share by Company (2020-2025)
Table 64. Japan Dry Eye Syndrome Revenue by Company (2020-2025) & (US$ Million)
Table 65. Japan Dry Eye Syndrome Revenue Market Share by Company (2020-2025)
Table 66. Japan Dry Eye Syndrome Sales by Type (2020-2025) & (K Units)
Table 67. Japan Dry Eye Syndrome Sales Market Share by Type (2020-2025)
Table 68. Japan Dry Eye Syndrome Sales by Distribution Channel (2020-2025) & (K Units)
Table 69. Japan Dry Eye Syndrome Sales Market Share by Distribution Channel (2020-2025)
Table 70. India Dry Eye Syndrome Sales by Company (2020-2025) & (K Units)
Table 71. India Dry Eye Syndrome Sales Market Share by Company (2020-2025)
Table 72. India Dry Eye Syndrome Revenue by Company (2020-2025) & (US$ Million)
Table 73. India Dry Eye Syndrome Revenue Market Share by Company (2020-2025)
Table 74. India Dry Eye Syndrome Sales by Type (2020-2025) & (K Units)
Table 75. India Dry Eye Syndrome Sales Market Share by Type (2020-2025)
Table 76. India Dry Eye Syndrome Sales by Distribution Channel (2020-2025) & (K Units)
Table 77. India Dry Eye Syndrome Sales Market Share by Distribution Channel (2020-2025)
Table 78. AbbVie Company Information
Table 79. AbbVie Description and Business Overview
Table 80. AbbVie Dry Eye Syndrome Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. AbbVie Dry Eye Syndrome Product
Table 82. AbbVie Recent Development
Table 83. Alcon Company Information
Table 84. Alcon Description and Business Overview
Table 85. Alcon Dry Eye Syndrome Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 86. Alcon Dry Eye Syndrome Product
Table 87. Alcon Recent Development
Table 88. Novartis Company Information
Table 89. Novartis Description and Business Overview
Table 90. Novartis Dry Eye Syndrome Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 91. Novartis Dry Eye Syndrome Product
Table 92. Novartis Recent Development
Table 93. Santen Pharma Company Information
Table 94. Santen Pharma Description and Business Overview
Table 95. Santen Pharma Dry Eye Syndrome Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 96. Santen Pharma Dry Eye Syndrome Product
Table 97. Santen Pharma Recent Development
Table 98. Johnson & Johnson Company Information
Table 99. Johnson & Johnson Description and Business Overview
Table 100. Johnson & Johnson Dry Eye Syndrome Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 101. Johnson & Johnson Dry Eye Syndrome Product
Table 102. Johnson & Johnson Recent Development
Table 103. Bausch & Lomb Company Information
Table 104. Bausch & Lomb Description and Business Overview
Table 105. Bausch & Lomb Dry Eye Syndrome Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 106. Bausch & Lomb Dry Eye Syndrome Product
Table 107. Bausch & Lomb Recent Development
Table 108. Thea pharmaceuticals Company Information
Table 109. Thea pharmaceuticals Description and Business Overview
Table 110. Thea pharmaceuticals Dry Eye Syndrome Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 111. Thea pharmaceuticals Dry Eye Syndrome Product
Table 112. Thea pharmaceuticals Recent Development
Table 113. URSAPHARM Company Information
Table 114. URSAPHARM Description and Business Overview
Table 115. URSAPHARM Dry Eye Syndrome Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 116. URSAPHARM Dry Eye Syndrome Product
Table 117. URSAPHARM Recent Development
Table 118. SIMILASAN Company Information
Table 119. SIMILASAN Description and Business Overview
Table 120. SIMILASAN Dry Eye Syndrome Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 121. SIMILASAN Dry Eye Syndrome Product
Table 122. SIMILASAN Recent Development
Table 123. Akorn Company Information
Table 124. Akorn Description and Business Overview
Table 125. Akorn Dry Eye Syndrome Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 126. Akorn Dry Eye Syndrome Product
Table 127. Akorn Recent Development
Table 128. United Laboratories Company Information
Table 129. United Laboratories Description and Business Overview
Table 130. United Laboratories Dry Eye Syndrome Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 131. United Laboratories Dry Eye Syndrome Product
Table 132. United Laboratories Recent Development
Table 133. Sun Pharmaceutical Company Information
Table 134. Sun Pharmaceutical Description and Business Overview
Table 135. Sun Pharmaceutical Dry Eye Syndrome Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 136. Sun Pharmaceutical Dry Eye Syndrome Product
Table 137. Sun Pharmaceutical Recent Development
Table 138. Jianfeng Group Company Information
Table 139. Jianfeng Group Description and Business Overview
Table 140. Jianfeng Group Dry Eye Syndrome Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 141. Jianfeng Group Dry Eye Syndrome Product
Table 142. Jianfeng Group Recent Development
Table 143. OmniVision Pharma Company Information
Table 144. OmniVision Pharma Description and Business Overview
Table 145. OmniVision Pharma Dry Eye Syndrome Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 146. OmniVision Pharma Dry Eye Syndrome Product
Table 147. OmniVision Pharma Recent Development
Table 148. Rohto Company Information
Table 149. Rohto Description and Business Overview
Table 150. Rohto Dry Eye Syndrome Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 151. Rohto Dry Eye Syndrome Product
Table 152. Rohto Recent Development
Table 153. Prestige Consumer Healthcare Company Information
Table 154. Prestige Consumer Healthcare Description and Business Overview
Table 155. Prestige Consumer Healthcare Dry Eye Syndrome Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 156. Prestige Consumer Healthcare Dry Eye Syndrome Product
Table 157. Prestige Consumer Healthcare Recent Development
Table 158. LION Company Information
Table 159. LION Description and Business Overview
Table 160. LION Dry Eye Syndrome Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 161. LION Dry Eye Syndrome Product
Table 162. LION Recent Development
Table 163. Kenvue (VISINE) Company Information
Table 164. Kenvue (VISINE) Description and Business Overview
Table 165. Kenvue (VISINE) Dry Eye Syndrome Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 166. Kenvue (VISINE) Dry Eye Syndrome Product
Table 167. Kenvue (VISINE) Recent Development
Table 168. Production Base and Market Concentration Rate of Raw Material
Table 169. Key Suppliers of Raw Materials
Table 170. Dry Eye Syndrome Distributors List
Table 171. Dry Eye Syndrome Customers List
Table 172. Dry Eye Syndrome Market Trends
Table 173. Dry Eye Syndrome Market Drivers
Table 174. Dry Eye Syndrome Market Challenges
Table 175. Dry Eye Syndrome Market Restraints
Table 176. Research Programs/Design for This Report
Table 177. Key Data Information from Secondary Sources
Table 178. Key Data Information from Primary Sources


List of Figures
Figure 1. Dry Eye Syndrome Product Picture
Figure 2. Global Dry Eye Syndrome Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Dry Eye Syndrome Sales Market Share by Type in 2024 & 2031
Figure 4. Artificial Tears Product Picture
Figure 5. Anti-inflammatory Drugs Product Picture
Figure 6. Others Product Picture
Figure 7. Global Dry Eye Syndrome Sales (US$ Million) by Distribution Channel (2020 & 2024 & 2031)
Figure 8. Global Dry Eye Syndrome Sales Market Share by Distribution Channel in 2024 & 2031
Figure 9. Hospital Examples
Figure 10. Retail Pharmacy Examples
Figure 11. Others Examples
Figure 12. Global Dry Eye Syndrome Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Dry Eye Syndrome Sales Growth Rate (2020-2031) & (US$ Million)
Figure 14. Global Dry Eye Syndrome Sales (K Units) Growth Rate (2020-2031)
Figure 15. Global Dry Eye Syndrome Price Trends Growth Rate (2020-2031) & (US$/Unit)
Figure 16. Dry Eye Syndrome Report Years Considered
Figure 17. Global Market Dry Eye Syndrome Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 18. Global Dry Eye Syndrome Revenue Market Share by Region: 2020 VS 2024
Figure 19. North America Dry Eye Syndrome Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. North America Dry Eye Syndrome Sales (K Units) Growth Rate (2020-2031)
Figure 21. Europe Dry Eye Syndrome Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. Europe Dry Eye Syndrome Sales (K Units) Growth Rate (2020-2031)
Figure 23. China Dry Eye Syndrome Revenue (US$ Million) Growth Rate (2020-2031)
Figure 24. China Dry Eye Syndrome Sales (K Units) Growth Rate (2020-2031)
Figure 25. Japan Dry Eye Syndrome Revenue (US$ Million) Growth Rate (2020-2031)
Figure 26. Japan Dry Eye Syndrome Sales (K Units) Growth Rate (2020-2031)
Figure 27. India Dry Eye Syndrome Revenue (US$ Million) Growth Rate (2020-2031)
Figure 28. India Dry Eye Syndrome Sales (K Units) Growth Rate (2020-2031)
Figure 29. Global Dry Eye Syndrome Revenue Share by Type (2020-2025)
Figure 30. Global Dry Eye Syndrome Sales Share by Type (2026-2031)
Figure 31. Global Dry Eye Syndrome Revenue Share by Type (2026-2031)
Figure 32. Global Dry Eye Syndrome Revenue Share by Distribution Channel (2020-2025)
Figure 33. Global Dry Eye Syndrome Revenue Growth Rate by Distribution Channel in 2020 & 2024
Figure 34. Global Dry Eye Syndrome Sales Share by Distribution Channel (2026-2031)
Figure 35. Global Dry Eye Syndrome Revenue Share by Distribution Channel (2026-2031)
Figure 36. Global Dry Eye Syndrome Sales Share by Company (2024)
Figure 37. Global Dry Eye Syndrome Revenue Share by Company (2024)
Figure 38. Global 5 Largest Dry Eye Syndrome Players Market Share by Revenue in Dry Eye Syndrome: 2020 & 2024
Figure 39. Dry Eye Syndrome Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 40. Manufacturing Cost Structure of Dry Eye Syndrome
Figure 41. Manufacturing Process Analysis of Dry Eye Syndrome
Figure 42. Dry Eye Syndrome Industrial Chain
Figure 43. Channels of Distribution (Direct Vs Distribution)
Figure 44. Distributors Profiles
Figure 45. Bottom-up and Top-down Approaches for This Report
Figure 46. Data Triangulation
Figure 47. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies